首页> Journal of immunotherapy (Hagerstown, Md. : 1997)> Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Gemma L,Owens

第一单位： Clinical and Experimental Immunotherapy Group.;Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester.

作者： Gemma L,Owens ^[1] ; Victoria E,Sheard ^[2] ; Milena,Kalaitsidou ^[2] ; Daniel,Blount ^[3] ; Yatish,Lad ^[3] ; Eleanor J,Cheadle ^[4] ; Richard J,Edmondson ^[5] ; Gurdeep,Kooner ^[3] ; David E,Gilham ^[2] ; Richard,Harrop ^[3]

作者单位： Clinical and Experimental Immunotherapy Group.;Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester. ^[1] Clinical and Experimental Immunotherapy Group. ^[2] Oxford BioMedica (UK) Limited, Windrush Court, Transport Way, Oxford, UK. ^[3] Targeted Therapy Group, Division of Cancer Sciences, Manchester Cancer Research Centre, School of Medical Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Withington. ^[4] Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester. ^[5]